Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/700
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmerena, J.en
dc.contributor.authorBrieger, D.en
dc.contributor.authorCoverdale, S.en
dc.contributor.authorAstley, C.en
dc.contributor.authorChew, D. P.en
dc.contributor.authorRankin, J.en
dc.date.accessioned2018-06-16T20:37:08Z-
dc.date.available2018-06-16T20:37:08Z-
dc.date.issued2007en
dc.identifier.citationNov 37, (11), 2007, p. 741-748en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/700-
dc.description.abstractBackground: Acute coronary syndromes (ACS) management is now well informed by guidelines extrapolated from clinical trials. However, most of these data have been acquired outside the local context. We sought to describe the current patterns of ACS care in Australia. Methods: The Acute Coronary Syndrome Prospective Audit study is a prospective multi-centre registry of ST-segment elevation myocardial infarction (STEMI), high-risk non-ST-segment elevation ACS (NSTEACS-HR) and intermediate-risk non-ST-segment elevation ACS (NSTEACS-IR) patients, involving 39 metropolitan, regional and rural sites. Data included hospital characteristics, geographic and demographic factors, risk stratification, in-hospital management including invasive services, and clinical outcomes. Results: A cohort of 3402 patients was enrolled; the median age was 65.5 years. Female and non-metropolitan patients comprised 35.5% and 23.9% of the population, respectively. At enrolment, 756 (22.2%) were STEMI patients, 1948 (57.3%) were high-risk NSTEACS patients and 698 (20.5%) were intermediate-risk NSTEACS patients. Evidence-based therapies and invasive management use were highest among suspected STEMI patients compared with other strata (angiography: STEMI 89%, NSTEACS-HR 54%, NSTEACS-IR 34%, P < 0.001) (percutaneous coronary intervention: STEMI 68.1%, NSTEACS-HR 22.2%, NSTEACS-IR 8.1%, P < 0.001). In hospital mortality was low (STEMI 4.0%, NSTEACS-HR 1.8%, NSTEACS-IR 0.1%, P < 0.001), as was recurrent MI (STEMI 2.4%, NSTEACS-HR: 2.8%, NSTEACS-IR 1.2%, P = 0.052). Conclusion: There appears to be an 'evidence-practice gap' in the management of ACS, but this is not matched by an increased risk of in-hospital clinical events. Objective evaluation of local clinical care is a key initial step in developing quality improvement initiatives and this study provides a basis for the improvement in ACS management in Australia.<br />en
dc.languageenen
dc.relation.ispartofInternal Medicine Journalen
dc.titleCurrent management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective auditen
dc.typeArticleen
dc.identifier.doi10.1111/j.1445-5994.2007.01435.xen
dc.relation.url<Go to ISI>://000249846500003en
dc.identifier.risid264en
dc.description.pages741-748en
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeArticle-
item.cerifentitytypePublications-
Appears in Sites:Sunshine Coast HHS Publications
Show simple item record

Page view(s)

254
checked on Jan 13, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.